What Are NAD Levels and How Can You Boost Them?

Understand the coenzyme NAD, essential for cellular energy and repair. Learn how lifestyle choices influence your levels and the strategies used to support them.

NAD+, short for nicotinamide adenine dinucleotide, is a molecule found in every cell of your body that helps convert food into energy, repair damaged DNA, and regulate hundreds of other biological processes. Your levels of it drop as you age, and that decline is now considered a contributor to many hallmarks of aging rather than just a side effect. The science around boosting NAD+ has exploded in recent years, with supplements, exercise protocols, and even IV infusions all claiming to restore what time takes away. Some of those claims hold up well; others get ahead of the evidence.

What NAD+ Actually Does in Your Cells

NAD+ and its reduced form, NADH, are essential for maintaining the chemical balance cells need to function and for driving cellular metabolism. Think of NAD+ as a shuttle bus for electrons: it picks them up during the breakdown of sugars and fats, delivers them to the machinery that produces ATP (the cell’s energy currency), and then cycles back for more. Without enough NAD+, that shuttle service slows down, and energy production suffers.

But energy production is only part of the story. NAD+ also fuels two important families of enzymes. Sirtuins are a group of proteins that depend on NAD+ to do their work, which includes regulating gene expression, maintaining genomic stability, and influencing how cells respond to stress. PARPs are DNA repair enzymes that also consume NAD+ as fuel: when your DNA gets damaged, PARPs swing into action and burn through NAD+ to fix the breaks. Both sirtuins and PARPs compete for the same limited pool of NAD+, which creates a tug-of-war inside your cells. When DNA damage is high and PARPs are working overtime, there is less NAD+ left for sirtuins to use for protective housekeeping tasks.

Why NAD+ Drops as You Age

Studies in both animals and humans confirm that tissue NAD+ concentrations decline with age. Research on human tissue found a strong negative correlation between NAD+ levels and age in both men and women, with the relationship being somewhat steeper in men. The decline is not caused by a single mechanism. At least three forces are at work simultaneously.

First, accumulated DNA damage over a lifetime keeps PARPs busy. As oxidative damage to DNA piles up, PARPs consume more and more NAD+ to make repairs, depleting the cellular supply. The same human tissue study found evidence that this PARP hyperactivation from oxidative damage is a major driver of NAD+ loss. Research in cardiomyocytes has shown that when PARP activation becomes excessive, NAD+ drops so far that the cells lose energy and function.

Second, an enzyme called CD38 ramps up dramatically with age. CD38 is a NADase, meaning it directly breaks down NAD+. Research has shown that CD38 protein levels increase two to three times during aging across liver, fat tissue, spleen, and skeletal muscle. Senescent cells, the so-called “zombie cells” that accumulate in aging tissues, promote this process by activating CD38-expressing immune cells.

Third, the recycling system that rebuilds NAD+ from its breakdown products becomes less efficient. Your body does not just make NAD+ from scratch every time; it salvages and recycles the molecule through a pathway that depends on an enzyme called NAMPT. NAMPT activity tends to decline with age, which means the resupply line slows down just as demand is rising.

NAD+ Precursor Supplements

Since you cannot simply swallow an NAD+ pill and have it reach your cells intact, researchers have focused on precursors: molecules your body can convert into NAD+. The two most widely studied are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both are converted into NAD+ through the salvage pathway, though they enter it at slightly different points. NMN is one step closer to NAD+ in the conversion chain, and a specific transporter called Slc12a8 in the small intestine can shuttle NMN directly into the bloodstream within about 15 minutes. NR, by contrast, enters cells through different transporters and gets phosphorylated inside the cell by enzymes called NRKs.

On the question of whether these precursors actually raise NAD+ in humans, the answer is clearly yes. A randomized trial of NR in older adults with mild cognitive impairment found a 2.6-fold increase in blood NAD+ in the supplement group. A dose-dependent trial of NMN in healthy middle-aged adults found blood NAD+ rose significantly at every dose tested (300, 600, and 900 mg daily), with the highest concentrations at 600 and 900 mg. Both compounds appear safe and well tolerated at these doses.

Does Raising NAD+ Actually Improve Health Outcomes?

This is where the picture gets more complicated, and where the gap between marketing and evidence matters most. Raising blood NAD+ is straightforward. Translating that into measurable health benefits has been harder to demonstrate.

A meta-analysis of randomized controlled trials looking at NMN supplementation found that while it reliably raised blood NAD+ levels, most clinically relevant outcomes (glucose metabolism, lipid levels) were not significantly different between the supplement and placebo groups. The authors concluded that the benefits of NMN supplementation may be exaggerated in the field. That is a sobering finding given how aggressively NMN is marketed as an anti-aging powerhouse.

Individual trials have found more encouraging results on secondary endpoints. The NMN dose-dependent trial mentioned earlier found that walking distance during a six-minute test improved significantly in the 300, 600, and 900 mg groups compared to placebo, and self-reported health scores also improved. Another trial in older adults found NMN supplementation maintained walking speed and improved sleep quality, with participants scoring better on daytime dysfunction and overall sleep measures compared to placebo.

For NR, the trial in older adults with mild cognitive impairment found modest reductions in epigenetic age as measured by biological clock analyses, and some changes in brain blood flow patterns, but cognitive test scores did not change over the study period. So the biological markers shifted in the right direction, but the participants did not get measurably sharper.

The honest read of the evidence right now: NAD+ precursors reliably raise NAD+ levels, appear safe, and show some promising signals on physical performance and sleep. But the big-ticket claims (reversing aging, preventing cognitive decline, curing metabolic disease) are still well ahead of the clinical data.

Exercise as an NAD+ Booster

If you are looking for the intervention with the most consistent evidence for supporting NAD+ metabolism, it might be the one that costs nothing. Exercise directly increases the activity of NAMPT, the rate-limiting enzyme in the NAD+ salvage pathway. A study in sedentary people found that just three weeks of exercise training increased skeletal muscle NAMPT protein by about 127%. That is a much larger change than what most supplement studies report.

Both aerobic exercise and resistance training produce this effect. In a study comparing the two, aerobic exercise increased NAMPT levels by roughly 12 to 28 percent depending on the age of the participants, while resistance exercise increased it by about 25 to 30 percent. The effect was present in both younger and older adults. Research in aged rats confirmed that regular exercise boosts NAD+ production through the NAMPT pathway and activates sirtuin-dependent protective mechanisms.

The appeal of exercise as an NAD+ strategy is that it addresses the supply side of the equation (boosting NAMPT and recycling capacity) rather than just flooding the system with precursors. It also comes bundled with every other benefit of physical activity, from cardiovascular health to improved mood, none of which a pill can replicate.

Caloric Restriction and Fasting

Fasting and caloric restriction also influence NAD+ levels, though by a somewhat different mechanism. Restricting calorie intake activates the de novo synthesis pathway, which builds NAD+ from the amino acid tryptophan rather than recycling nicotinamide. Research has shown that the organ-protective effects of caloric restriction depend on this pathway, and that blocking it eliminates much of the benefit. Broader reviews have noted that fasting, caloric restriction, and low glucose availability all upregulate NAD+ levels at the cellular level.

There is an elegant logic here: when food is scarce, cells ramp up NAD+ production to maximize energy extraction from whatever nutrients are available. That metabolic shift engages the same sirtuin pathways that NAD+ supplements aim to activate. Whether intermittent fasting in humans produces a clinically meaningful and sustained increase in NAD+ is still being studied, but the cellular machinery for it is well established.

NAD+ and Your Body Clock

One aspect of NAD+ biology that gets overlooked in the supplement conversation is its deep connection to circadian rhythms. NAD+ levels naturally oscillate over the course of a day, driven by rhythmic production of NAMPT that follows your circadian clock. In turn, NAD+-dependent sirtuins feed back into that clock by modifying core clock proteins, creating a two-way regulatory loop.

This means that disrupted sleep and irregular schedules do not just make you tired; they may interfere with the daily rhythm of NAD+ production. The connection also runs in the other direction: the sleep quality improvements seen with NMN supplementation in older adults could partly reflect NAD+’s role in reinforcing circadian signaling. If you are taking NAD+ precursors to improve energy and vitality but your sleep schedule is chaotic, you may be working against the very system you are trying to support.

The Cancer Question

A concern that comes up frequently in online discussions about NAD+ boosting is whether increasing NAD+ could feed cancer. This is not an unreasonable worry. Cancer cells are highly metabolically active, and increased NAD+ levels enhance glycolysis, which fuels tumor growth. NAMPT, the key enzyme in NAD+ recycling, is frequently amplified in several types of cancer cells. In fact, researchers are investigating NAMPT inhibitors as potential anti-cancer drugs precisely because depleting NAD+ in tumor cells suppresses their ability to grow.

Does this mean taking NMN or NR supplements will give you cancer? No clinical trial has found that, and the supplementation studies conducted so far have not reported increased cancer rates. But these trials are short, typically spanning weeks to a few months, and cancer development takes years. The theoretical concern remains open, and it is one of the reasons the field needs longer and larger trials. People with a history of cancer, or those undergoing cancer treatment, should discuss NAD+ supplementation with their oncologist rather than self-prescribing based on longevity influencer advice.

IV NAD+ Infusions

NAD+ IV drips have become popular at boutique wellness clinics, with single sessions sometimes costing hundreds of dollars. The pitch is that infusing NAD+ directly into the bloodstream bypasses the digestive system and delivers a more potent dose. In practice, the experience is rough. A retrospective pilot study comparing IV NAD+ infusions with IV NR found that all six participants receiving NAD+ reported moderate to severe abdominal cramping, diarrhea, nausea, vomiting, increased heart rate, throat pain, congestion, and chest pressure during the infusion. The NR group, by contrast, experienced only minor tingling and cramping. NAD+ infusions also took substantially longer, averaging about 97 minutes compared to 37 minutes for NR, a roughly 60 percent reduction in chair time for NR recipients.

Whether IV delivery produces meaningfully better outcomes than oral supplements is unproven. The side effect profile alone should give most people pause, and the study just described involved only a handful of participants. The cost-to-evidence ratio for IV NAD+ is currently quite poor.

Can You Test Your NAD+ Levels?

Several companies now offer consumer tests that claim to measure your NAD+ status. A validation study of one fingerstick blood assay found strong agreement between the rapid test and lab-grade mass spectrometry methods. That is encouraging for the technology, but knowing your blood NAD+ number has limited practical value right now. There are no established clinical reference ranges that tell you “your NAD+ is too low, take X.” Blood levels also reflect whole-blood NAD+ and may not perfectly correspond to what is happening inside specific tissues like your brain or muscles. Testing can confirm whether a supplement is raising your blood NAD+ (useful for making sure a product is not inert), but interpreting the absolute number requires more population data than we currently have.

NAD+ and Nerve Health

Beyond the aging and energy narrative, NAD+ plays a specific role in protecting nerve fibers. Axon degeneration, the process by which the long extensions of nerve cells break down, is governed in large part by the balance between two enzymes: NMNAT2, which makes NAD+, and SARM1, which destroys it. When NMNAT2 is depleted (as happens after nerve injury), SARM1 activates and rapidly consumes the remaining NAD+, triggering the axon to self-destruct. This mechanism is relevant to conditions like peripheral neuropathy and neurodegenerative diseases, and it has made SARM1 a drug target in its own right. Whether general NAD+ supplementation influences this specific axis in humans remains to be seen, but the biology suggests that maintaining healthy NAD+ levels could theoretically protect nerves from damage cascades.

Tissue-Specific Differences in NAD+ Biology

Not every organ handles NAD+ the same way. The brain and pancreas, for instance, have very low levels of intracellular NAMPT, the enzyme that recycles NAD+ inside cells. These organs depend more heavily on circulating NMN carried through the bloodstream by an extracellular form of NAMPT to maintain their internal NAD+ supply. Skeletal muscle, which has high energy demands, relies more on its own internal recycling machinery.

This matters because a supplement that raises blood NAD+ does not necessarily raise it equally in every tissue. The brain’s dependence on circulating precursors could make it more responsive to oral supplementation, or it could mean the blood-brain barrier limits delivery. These tissue-specific dynamics are one reason why animal studies showing dramatic benefits do not always translate neatly to human trials, and why exercise (which directly stimulates NAMPT in the muscles being used) may have a more targeted effect on skeletal muscle NAD+ than a capsule does.